| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.25 | 7e-12 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.25 | 2e-10 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.22 | 7e-10 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.18 | 8e-10 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.29 | 7e-09 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.2 | 8e-09 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-08 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-08 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-07 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-07 |